CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab Treatment
Ye Jin Ahn, Hyung Bin Hwang, Sung Kun Chung
Korean J Ophthalmol. 2014;28(2):177-180.   Published online March 14, 2014
DOI: https://doi.org/10.3341/kjo.2014.28.2.177

Excel Download

Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab Treatment
Korean Journal of Ophthalmology. 2014;28(2):177   Crossref logo
Link1 Link2 Link3

Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
Case Reports in Ophthalmology. 2020;11(3):652-657   Crossref logo
Link1 Link2

Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization
Acta Ophthalmologica. 2009;87(6):653-658   Crossref logo
Link1 Link2

Ranibizumab versus Bevacizumab for the Treatment of Idiopathic Choroidal Neovascularization: 2-Year Results
European Journal of Ophthalmology. 2015;26(3):262-267   Crossref logo
Link1 Link2 Link3

Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 Eyes
Journal of Ophthalmology. 2016;2016:1-4   Crossref logo
Link1 Link2 Link3

The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization
International Ophthalmology. 2013;33(5):507-513   Crossref logo
Link1 Link2 Link3

Two Cases of Corneal Neovascularization Improved by Electrocauterization and Subconjunctival Bevacizumab Injection
Journal of the Korean Ophthalmological Society. 2017;58(8):981   Crossref logo
Link1 Link2 Link3

Subconjunctival injection of bevacizumab (Avastin®) for corneal neovascularization
Acta Ophthalmologica. 2009;87:0-0   Crossref logo
Link1 Link2

Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization
Saudi Journal of Ophthalmology. 2017;31(2):99-105   Crossref logo
Link1 Link2

The Effect of Bevacizumab versus Ranibizumab in the Treatment of Corneal Neovascularization: A Preliminary Study
Korean Journal of Ophthalmology. 2013;27(4):235   Crossref logo
Link1 Link2 Link3